Hearing on Biomedical Research – Keeping America’s Edge in Innovation
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.
Treatment Action Group (TAG) decries the vicious and inchoate attacks on HHS since the advent of the new administration, which have escalated significantly over the past week.
This policy brief describes the crucial role NIH plays in supporting research on new products to prevent, diagnose, and cure TB. This research is especially important at a time when new forms of drug resistance are emerging globally, and rates of TB are rising in the U.S. With continued and increased funding, NIH can protect Americans from the growing threat of TB at home and abroad.
TAG is deeply concerned about the Trump administration’s potential plans to eliminate vital HIV programs at the CDC’s Division of HIV Prevention (DHP) and other programs in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).
The nomination of Dr. Jay Bhattacharya for Director of the United States National Institutes of Health (NIH) continues the pattern of un- and under-qualified nominees put forward by the current administration.
This title of this page is one of the quotes by Mark Harrington from his recent appearance on +Life Media with TAG board member Karl Schmid. We rate this video absolutely must watch!
TAG was proud to sign on to this 2/3/25 letter created by HIV Health Care Access Working Group (HHCAWG) of the Federal AIDS Policy Partnership (FAPP).
The new U.S. presidential administration has issued several executive orders, which use pseudo-scientific claims to deny the existence of transgender and non-binary people.
Treatment Action Group’s (TAG) most important fundraising event of the year is the Research in Action Awards, which honor the best and brightest activists, researchers, leaders, and scientists whose work has been integral in ending HIV, tuberculosis (TB), and hepatitis C (HCV).
Treatment Action Group (TAG) elected three new members to its Board of Directors in May 2024. Board President Ivy Kwan Arce said, "TAG is reinvigorating its Board in alignment with our vision, mission, and values.